A national survey of immunization practices following allogeneic bone marrow transplantation

JAMA

Volumn 277, Issue 14, 1997, Pages 1148-1151

  Henning, Kelly J ^a,b,c   White, Mary H ^a   Sepkowitz, Kent A ^a   Armstrong, Donald ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; VACCINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL PRACTICE; DRUG USE; HUMAN; IMMUNIZATION; PRIORITY JOURNAL;

EID: 0030914323     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.14.1148     Document Type: Article

References (31)

1. Horowitz MM. New IBMTR/ABMTR slides summarize current use and outcome of allogeneic and autologous transplants. IBMTR Newslett. July 1995; 2:1,3-8.
2. Ljungman P, Wikland-Hammarsten M, Duraj V, et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis. 1990;162:496-500.
3. Lum LG, Munn NA, Schanfield MS, Storb R. The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood. 1986;67;582-587.
4. Lum LG, Noges JE, Beatty P, et al. Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted or HLA identical marrow grafts. Bone Marrow Transplant. 1988;3:399-406.
5. Volti SL, Mauro L, Di Gregorio F, et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant. 1994;14:225-227.
6. Ljungman P, Lewensohon-Fuchs I, Hammarstrom V, et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood. 1994;84:657-663.
7. Ljungman P, Fridell E, Lonnqvist B, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis. 1989;159:610-615.
8. Ljungman P, Duraj V, Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant. 1991; 7:89-93.
9. Ljungman P, Levenshohn-Fuchs I, Aschan J, Lonnqvist B, Ringden O, Winiarskl J. Immunization of bone marrow transplant patients with live attenuated measles vaccine: efficacy and safety. In: Program and abstracts of the Eighth International Symposium on Infections in the Immunocompromised Host; June 19-22, 1994; Davos, Switzerland. Abstract 50.
10. Wingard JR. Advances in the management of infectious complications after bone marrow transplantation. Bone Marrow Transplant. 1990;6:371-383.
11. Aucouturier P, Barra A, Intrator L. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood. 1987;70:779-785.
12. Winston DJ, Ho WG, Schiffman G, Champlain RE, Feig SA, Gale P. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med. 1983;143:1735-1737.
13. Guinan EC, Molrine DC, Antin JH, et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation. 1994;57: 677-684.
14. Giebink GS, Warkentin PI, Ramsey NK, Kersey JH. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis. 1986;154:590-596.
15. Quinti I, Velardi A, LeMoli S, et al. Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. J Clin Immunol. 1990;10:160-166.
16. Engelhard D, Nagler A, Hardan I, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T-cell depleted and autologous BMT recipients. Bone Marrow Transplant. 1993; 11:1-5.
17. Ambrosino DM, Molrine DC. Critical appraisal of immunization strategies for prevention of infection in the compromised host. Hematol Oncol Clin North Am. 1993;7:1027-1050.
18. Ljungman P, Cordonnier C, de Block R, et al. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European group for blood and marrow transplantation. Bone Marrow Transplant. 1995;15:455-460.
19. Somani J, Larson RA. Reimmunization after allogeneic bone marrow transplantation. Am J Med. 1995;98:389-398.
20. Brandt L, Broadbent V. A survey of recommendations given to patients going home after bone marrow tranplant. Arch Dis Child. 1994;71:529-531.
21. National Marrow Donor Program. Transplant Center Access Directory. 10th ed. Minneapolis, Minn: National Marrow Donor Program; April 1995.
22. Dean AD, Dean JA, Burton JH, Dicker RC. Epi Info, Version 5. Atlanta, Ga: Centers for Disease Control; 1990.
23. Gardner P, Schaffner W. Immunization of adults. N Engl J Med. 1993;328:1252-1258.
24. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR Morb Mortal Wkly Rep. 1993;42:1-18.
25. Winston DJ, Schiffman G, Wang DC, et al. Pneumococcal infections after human bone marrow transplantation. Ann Intern Med. 1979;91:835-841.
26. Whimbey E, Elting LS, Couch RB, et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant. 1994;13:437-440.
27. Aschan J, Ringden O, Ljungman P, Anderson J, Lewensohn-Fuchs I, Forsgren M. Influenza B in transplant patients. Scand J Infect Dis. 1989;21: 349-350.
28. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 1996;45(RR-5):1-24.
29. Rosendahl C, Bender-Goetze C, Deinhardt F, Kolb HJ, Hass R. Immunization against hepatitis B in BMT and leukemia patients. Exp Hematol. 1985; 13(suppl 17):104-111.
30. Ilan Y, Nagler A, Adler R, et al. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology. 1993;18:246-252.
31. Ilan Y, Nagler A, Shouval D, et al. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipients following treatment with peripheral blood lymphocytes from immunized donors. Clin Exp Immunol. 1994; 97:299-302.